Bitancor, Alexander C.
HRN: 22-11-62 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/26/2022
CLINDAMYCIN 150MG/ML, 4ML (AMP)
10/26/2022
11/02/2022
IV
600mg
Q6hrs
T/C Aspiration Pneumonia
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes